Published in J Pediatr Gastroenterol Nutr on October 01, 1998
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants | NCT00249951
Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily. Microbiol Mol Biol Rev (2000) 2.03
Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One (2011) 1.25
The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr (2013) 1.07
Urolithiasis in infants: evaluation of risk factors. World J Urol (2012) 0.90
Urolithiasis in the first year of life. Pediatr Nephrol (2010) 0.87
Is oxidative stress related to childhood urolithiasis? Pediatr Nephrol (2014) 0.78
Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula. Eur J Pediatr (2003) 0.77
Assessment of risk factors of pediatric urolithiasis in Egypt. Transl Androl Urol (2012) 0.75
Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol. Pediatr Nephrol (2014) 0.75
Developmental changes of oxalate excretion in enterally fed preterm infants. J Inherit Metab Dis (2008) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Direct text entry in electronic progress notes. An evaluation of input errors. Methods Inf Med (2003) 4.00
Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med (2001) 2.89
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
Expression profiling of the maize flavonoid pathway genes controlled by estradiol-inducible transcription factors CRC and P. Plant Cell (2000) 2.17
Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis (1992) 1.71
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase. J Med Chem (1989) 1.64
High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr (1992) 1.64
Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr (1992) 1.58
Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor. Science (1987) 1.57
Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57
Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr (2013) 1.57
[Acquired peeling skin syndrome in an adult]. Ann Dermatol Venereol (2000) 1.51
Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (1995) 1.51
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol (1997) 1.49
Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin Padiatr (2011) 1.46
Transplantation outcomes in primary hyperoxaluria. Am J Transplant (2010) 1.45
Unmasking of hypoparathyroidism in familial partial DiGeorge syndrome by challenge with disodium edetate. N Engl J Med (1988) 1.43
[Prevalence and management of chronic wounds in 14 geriatric institutions of the Haut-Rhin]. Ann Dermatol Venereol (2007) 1.43
Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol (1994) 1.41
IgA nephropathy: to treat or not to treat? Nephron (1997) 1.40
Infantile myelofibrosis with nephromegaly secondary to myeloid metaplasia. Clin Pediatr (Phila) (1991) 1.39
Long-term reduction in bone mass after severe burn injury in children. J Pediatr (1995) 1.37
Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide. Chirality (1995) 1.25
Bone disease in burn patients. J Bone Miner Res (1993) 1.23
Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr (1997) 1.22
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res (1999) 1.15
Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int (1999) 1.13
Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol (1999) 1.13
Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res (1999) 1.12
Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment. Neonatology (2006) 1.11
Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab (1998) 1.10
Misuse of metered-dose inhalers in hospitalized patients. Chest (1994) 1.09
Laryngo-tracheo-oesophageal cleft. Clinical features, diagnosis and therapy. Eur J Pediatr (1983) 1.09
Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr (1996) 1.07
Endpoints of resuscitation of critically injured patients: normal or supranormal? A prospective randomized trial. Ann Surg (2000) 1.06
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 5. 3',5'-Dimethoxy-4'-substituted-benzyl analogues of trimethoprim. J Med Chem (1981) 1.05
The use of the double-balloon enteroscope for endoscopic retrograde cholangiopancreatography and biliary stent placement after Roux-en-Y hepaticojejunostomy. Endoscopy (2007) 1.03
REM sleep and NREM sleep in narcolepsy and hypersomnia. Electroencephalogr Clin Neurophysiol (1969) 1.03
2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes. J Med Chem (1987) 1.01
Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res (1990) 1.00
[Treatment tactics and late results in early infection following osteosynthesis]. Unfallchirurgie (1986) 0.99
Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int (2008) 0.99
Phospholipid specificity of bovine heart bc1 complex. Eur J Biochem (1990) 0.99
Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit. J Biol Chem (1988) 0.99
Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int (2008) 0.99
Participation of the central nervous system in decompression. Ind Med Surg (1966) 0.99
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol (2000) 0.98
Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol Exp Ther (1969) 0.98
Some pyrimidines of biological and medicinal interest. 3. Prog Med Chem (1971) 0.97
Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol (2004) 0.97
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight. J Perinatol (2006) 0.96
A quantitative polygraphic study of daytime somnolence and sleep in patients with excessive diurnal sleepiness. Schweiz Arch Neurol Neurochir Psychiatr (1984) 0.96
Hydroxylated metabolites of thalidomide: formation in-vitro and in-vivo in man. J Pharm Pharmacol (1998) 0.96
Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol (1997) 0.96
Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr (2010) 0.95
Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am J Physiol Heart Circ Physiol (2001) 0.95
Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia. AJNR Am J Neuroradiol (1993) 0.95
The diuretic phase of respiratory distress syndrome and its relationship to oxygenation. J Pediatr (1981) 0.95
Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int (1988) 0.94
Latent hypoparathyroidism in children with conotruncal cardiac defects. Circulation (1996) 0.94
Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr Nephrol (2000) 0.93
Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Acta Paediatr (2009) 0.92
Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci (1981) 0.92
Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia (1986) 0.92
Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr (1991) 0.92
Recent progress in the medicinal chemistry of 2,4-diaminopyrimidines. Prog Med Chem (1982) 0.92
Neonatal haemochromatosis: report of a patient with favourable outcome. Eur J Pediatr (1997) 0.91
Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants. Genes Immun (2006) 0.91
Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. Blood (1998) 0.91
Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J Pediatr (1997) 0.90
Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol (1995) 0.90
Simultaneous determination of oxalate, citrate and sulfate in children's plasma with ion chromatography. Kidney Int (1998) 0.90
Protonated state of methotrexate, trimethoprim, and pyrimethamine bound to dihydrofolate reductase. Arch Biochem Biophys (1983) 0.90
Hypersomnia with "sleep drunkenness". Arch Gen Psychiatry (1972) 0.90
Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis. Clin Immunol Immunopathol (1998) 0.90
Kleine-Levin syndrome ethiopathogenesis and treatment. Acta Univ Carol Med Monogr (1988) 0.90
Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy). Pediatr Nephrol (1992) 0.89
Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int (2000) 0.89
DR2-negative narcolepsy. Lancet (1986) 0.89
25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr (1982) 0.89
Sympathetic cooling of complex molecular ions to millikelvin temperatures. Phys Rev Lett (2006) 0.88
Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J Bone Miner Res (1989) 0.88
Renal functional reserve in long-term survivors of unilateral Wilms tumor. J Pediatr (1991) 0.88
Heredofamilial aspects of narcolepsy and hypersomnia. Schweiz Arch Neurol Neurochir Psychiatr (1972) 0.88
Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int (1998) 0.87
Narcolepsy and hypersomnia: review and classification of 642 personally observed cases. Schweiz Arch Neurol Neurochir Psychiatr (1976) 0.87
Penetration of parenterally administered rifampicin into bone tissue. Chemotherapy (1984) 0.87
Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet (1997) 0.87
Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol (1991) 0.87
Evidence for calcium-dependent control of 1,25-dihydroxyvitamin D3 production by rat kidney proximal tubules. J Biol Chem (1986) 0.87
Live chilling of Atlantic salmon: physiological response to handling and temperature decrease on welfare. Fish Physiol Biochem (2011) 0.87
Hypercalciuria in clinical pediatrics. A review. Clin Pediatr (Phila) (1984) 0.87
Acute renal failure in the pediatric patient. Adv Ren Replace Ther (1997) 0.86
[Postoperative pain therapy in pediatrics. Results of a representative survey in Germany]. Anaesthesist (2001) 0.86
Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues. J Med Chem (1985) 0.86
Familial sleep paralysis. Schweiz Arch Neurol Neurochir Psychiatr (1968) 0.86
Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr (1990) 0.86